The effect of atorvastatin on lung function and morbidity as add-on therapy in normolipid asthmatic patients. A double-blind placebo controlled randomized cross-over trial.

Trial Profile

The effect of atorvastatin on lung function and morbidity as add-on therapy in normolipid asthmatic patients. A double-blind placebo controlled randomized cross-over trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Atorvastatin (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jun 2016 Last checked against Australian New Zealand Clinical Trials Registry record.
    • 02 Sep 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top